Volume 5, Issue 1, Pages 98-100 (January 2019) Renal clearance and intracellular half-life essentially determine methotrexate toxicity: A case series Yukiyasu Arakawa, MD, PhD, Akiko Arakawa, MD, PhD, Secil Vural, MD, Rahul Mahajan, MD, PhD, Jörg Christoph Prinz, MD JAAD Case Reports Volume 5, Issue 1, Pages 98-100 (January 2019) DOI: 10.1016/j.jdcr.2018.10.022 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Necrotizing gingivitis and mucosal ulceration indicating bone-marrow suppression and incipient agranulocytosis during low-dose MTX treatment. JAAD Case Reports 2019 5, 98-100DOI: (10.1016/j.jdcr.2018.10.022) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Monomorphic erosions of all pre-existing psoriatic plaques as an early sign of MTX toxicity and myelosuppression. JAAD Case Reports 2019 5, 98-100DOI: (10.1016/j.jdcr.2018.10.022) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions